R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 30,213 shares at $8.60 ($259K) on 2023-03-07, disclosed to the SEC on 2023-03-08.
Open-market sale of $259k ADPT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.57 | 6,529 | $56K | 21.6% |
| 2 | $8.57 | 6,529 | $56K | 21.6% |
| 3 | $8.60 | 17,155 | $148K | 56.9% |
| Total | $8.59 avg | 30,213 | $259K | 100% |
| Filing → |
| ADPT | SELL | 2022-10-11 | $23K | — | Filing → |
| ADPT | SELL | 2022-07-08 | $32K | — | Filing → |
| ADPT | SELL | 2022-04-08 | $11K | — | Filing → |